-
Signature
-
/s/ Samantha Lagocki, POA
-
Issuer symbol
-
EQIX
-
Transactions as of
-
01 Sep 2023
-
Net transactions value
-
-$534,688
-
Form type
-
4
-
Filing time
-
06 Sep 2023, 16:58:35 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EQIX |
Common Stock |
Options Exercise |
$0 |
+1,782 |
+44550% |
$0.000000 |
1,786 |
01 Sep 2023 |
Direct |
F1 |
| transaction |
EQIX |
Common Stock |
Sale |
$20,607 |
-27 |
-1.5% |
$763.23 |
1,759 |
05 Sep 2023 |
Direct |
|
| transaction |
EQIX |
Common Stock |
Sale |
$103,324 |
-135 |
-7.7% |
$765.36 |
1,624 |
05 Sep 2023 |
Direct |
F2 |
| transaction |
EQIX |
Common Stock |
Sale |
$93,529 |
-122 |
-7.5% |
$766.64 |
1,502 |
05 Sep 2023 |
Direct |
F3 |
| transaction |
EQIX |
Common Stock |
Sale |
$171,114 |
-223 |
-15% |
$767.33 |
1,279 |
05 Sep 2023 |
Direct |
F4 |
| transaction |
EQIX |
Common Stock |
Sale |
$125,325 |
-163 |
-13% |
$768.86 |
1,116 |
05 Sep 2023 |
Direct |
F5 |
| transaction |
EQIX |
Common Stock |
Sale |
$20,789 |
-27 |
-2.4% |
$769.95 |
1,089 |
05 Sep 2023 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EQIX |
Restricted Stock Unit |
Options Exercise |
$0 |
-1,782 |
-20% |
$0.000000 |
7,122 |
01 Sep 2023 |
Common Stock |
1,782 |
$0.000000 |
Direct |
F6, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: